Sangamo Therapeutics
SGMO
#9118
Rank
HK$0.97 B
Marketcap
HK$2.35
Share price
15.38%
Change (1 day)
-53.48%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total debt is HK$0.19 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.23 B-20.26%
2023-12-31HK$0.29 B-11.64%
2022-12-31HK$0.33 B-10.16%
2021-12-31HK$0.37 B14.91%
2020-12-31HK$0.32 B-5.66%
2019-12-31HK$0.34 B59.5%
2018-12-31HK$0.21 B12.19%
2017-12-31HK$0.19 B531.79%
2016-12-31HK$30.59 M
2015-12-31N/A
2001-12-31HK$2.22 M
1999-12-31HK$2.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$375.65 B 188,434.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$427.93 B 214,673.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.54 B 25,770.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$153.59 B 76,984.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$195.42 B 97,980.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$386.67 B 193,964.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$10.01 B 4,928.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$4.74 B 2,283.03%๐Ÿ‡บ๐Ÿ‡ธ USA